Xiaofeng Liu

NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models

Deborah H. Charych, Ute Hoch, John L. Langowski et al. · Clinical Cancer Research · 2016 · 392 citations

Life Sciences, Immunology, Oncology +17

Antrodin A from<i>Antrodia camphorata</i>modulates the gut microbiome and liver metabolome in mice exposed to acute alcohol intake

Zhen-Wei Yi, Xiaofeng Liu, Lihong Liang et al. · Food & Function · 2021 · 98 citations

Life Sciences, Biochemistry, Pharmacology +16

Inhibition of P2X7 receptors improves outcomes after traumatic brain injury in rats

Xiaofeng Liu, Zhengqing Zhao, Ruihua Ji et al. · Purinergic Signalling · 2017 · 64 citations

Medicine, Neuroscience, Pharmacology +14

Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2<i>H</i>-benzo[<i>f</i>]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes

Shiliang Li, Hongling Xu, Shichao Cui et al. · Journal of Medicinal Chemistry · 2016 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor

Qiao Li, Lina Quan, Jiankun Lyu et al. · Oncotarget · 2016 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17